|
|
|
|
|
|
by brixon
4333 days ago
|
|
|
It's not a cost savings in the long run.
1. They will spread it to more people.
2. The disease causes more issues that will end up costing more than this drug. This will not be an issue when the masses that have Hep-C now are cured. This is mostly a short term financing problem. Would you rather solve the issue for $1X now or pay $3-5X over time to deal with it. I would rather cure the masses now and lower the long term medical costs. |
|
|